4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-26-040896
Chief Financial Officer sold 14,000 shares at $3.55 ($49,650)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gagnon Robert E. Chief Financial Officer | 2026-10-23 | Sale 10b5-1 | −14,000 | $3.55 | $49,650 | 542,375 | D |
| Open-market sales · 14,000 sh · avg $3.55 · $49,650 | |||||||
Loading xslF345X06/form4.xml…